Southern Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$509K Buy
8,834
+167
+2% +$9.59K 0.13% 39
2026
Q1
$526K Buy
8,667
+74
+0.9% +$4.31K 0.15% 33
2025
Q4
$464K Buy
+8,593
New +$413K 0.13% 40

Other funds holding BMY

Southern Financial Group's BMY Position: Q2 2026 in Review

Southern Financial Group increased its Bristol-Myers Squibb (BMY) stake by 1.9% in Q2 2026, buying an estimated $9.59K and bringing the position to 8,834 shares worth $509K. The position accounts for 0.13% of the portfolio, ranked #39.

Southern Financial Group first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $526K in Q1 2026. 1,399 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Southern Financial Group held 8,834 shares of Bristol-Myers Squibb worth $509K as of Q2 2026.
  • Southern Financial Group bought 167 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.59K.
  • Bristol-Myers Squibb made up 0.13% of Southern Financial Group's portfolio in Q2 2026, its #39 holding.
  • Southern Financial Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Southern Financial Group's Bristol-Myers Squibb position peaked at $526K in Q1 2026.
  • 1,399 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Southern Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.